Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
254 participants
OBSERVATIONAL
2008-03-31
2009-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intervention for HIV-Positive Black Young Men Who Have Sex With Men (YMSM)
NCT01502618
HIV Prevention Among Vulnerable Male Youth
NCT01771237
Peer-led Social Media Intervention to Prevent HIV Among Young Men Who Have Sex With Men (YMSM)
NCT04417946
Testing a Secondary Prevention Intervention for HIV-Positive Black Young Men Who Have Sex With Men
NCT01751594
Pre-Exposure Prophylaxis in YMSM
NCT01033942
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phase 1
Male, HIV+ participants from ages 16-24 who have had sex with another male in the past year and acquired HIV behaviorally. Participants will be drawn from four participating AMTU sites.
No interventions assigned to this group
Phase 2
Male, HIV+ participants from ages 16-24 who have had sex with another male in the past year and acquired HIV behaviorally. Participants will be drawn from all fifteen AMTU sites.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HIV-infected as documented by medical record review or verbal verification with referring professional;
* Between the age of 16 years, 0 days to 24 years, 364 days at the time of informed consent/assent;
* HIV infection occurred through sexual or substance use behavior of the participant;
* Ability to understand both written and spoken English; and
* History of at least one sexual encounter involving either anal or oral penetration (either receptive or insertive) with a male partner during the 12 months prior to enrollment.
Exclusion Criteria
* Transfusion acquired HIV infection;
* Presence of serious psychiatric symptoms (active hallucinations, thought disorder) that would impair participants' ability to complete the study measures;
* Visibly distraught (suicidal, homicidal, exhibiting violent behavior); or
* Intoxicated
16 Years
24 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
National Institute of Mental Health (NIMH)
NIH
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gary W Harper
Role: STUDY_CHAIR
Adolescent Trials Network
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hopsital of Los Angeles
Los Angeles, California, United States
University of California at San Francisco
San Francisco, California, United States
Children's National Medical Center
Washington D.C., District of Columbia, United States
Children's Diagnostic and Teatment Center
Fort Lauderdale, Florida, United States
University of Miami
Miami, Florida, United States
University of South Florida College of Medicine
Tampa, Florida, United States
John Stroger Jr. Hospital of Cook County
Chicago, Illinois, United States
Children's Memorial Hospital
Chicago, Illinois, United States
Tulane Medical Center
New Orleans, Louisiana, United States
University of MD School of Medicine
Baltimore, Maryland, United States
Mount Sinai Medical Center
New York, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
St. Jude Children's Research Hospital
Memphis, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ATN 070
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.